Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs/File Photo
The British drugmaker said it would give details on June 23 on its plan to separate next year into an over-the-counter business and another for prescription drugs and vaccines. Walmsley, a former head of GSK's consumer business, became CEO in 2017 despite some investor pressure to name an outsider and such calls may grow with Elliott's arrival on the register.
Preparations have hurt earnings, but GSK hopes the streamlining of operations will pay off in the long term.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Most disliked video on YouTube..